(3beta,5alpha,8xi,11alpha,12beta,14beta,17alpha)-12-Acetoxy-3-{[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-beta-D-allopyranosyl)-3-O-methyl-alpha-D-arabino-hexopyranosyl]oxy}-20-oxo-8,14-epoxypregnan-11-yl 2 -methylpropanoate(CAS: 1260252-18-3)

This compound is subject to various regulatory guidelines including GHS classification, REACH regulations, and FDA/EPA requirements. It is important to follow these guidelines for proper handling and storage to ensure safety and compliance. Detailed guidelines can be found in the respective regulatory documents.

Several alternatives can be used in the synthesis of this compound, including various reagents such as isomers, analogs, and common alternatives. These include methyl esters, ethyl esters, and other related compounds that serve similar functions in biological and chemical processes.

The research and market trends for this compound are currently driven by its potential applications in pharmaceuticals and biotechnology. Recent studies focus on its biological activities and therapeutic potentials. However, due to its complexity, there is ongoing research to develop more efficient and sustainable synthesis methods.

Waste containing this compound should be handled by collecting it in appropriate containers and disposing of it through professional waste disposal services. Incineration is a common method, but environmental protection precautions should be taken to minimize environmental impact. Compliance with local and international environmental regulations is essential.